Dr. Gordon Christopher Steinagle, M.P.H.,D.O. Preventive Medicine - Occupational Medicine Medicare: Not Enrolled in Medicare Practice Location: 51 Webster St, N Tonawanda, NY 14120 Phone: 716-692-6541 Fax: 716-692-7091 |
News Archive
Xenon Pharmaceuticals Inc. announced today that it has initiated a phase 2 clinical trial evaluating its novel topical XEN402 therapy for the treatment of PHN.
Clinical Genomics, a private company developing innovative diagnostic tools for colorectal cancer, today announced that data supporting its two-gene circulating tumor DNA (ctDNA) blood test for post-surgical monitoring of colorectal cancer (CRC) recurrence have been published online by Cancer Medicine, and will appear in the October issue.
Following the news that Japan's Fujifilm Holdings Corp has agreed to acquire Hitachi Ltd.'s diagnostic imaging business for approximately JPY179bn (US$1.64bn); Rohit Anand, Practice Head of Medical Devices at GlobalData, a leading data and analytics company, offers his view.
Over the past 30 years, the number of adults (aged 30-79 years) living with hypertension worldwide has doubled—rising from an estimated 331 million women and 317 million men in 1990, to 626 million women and 652 million men in 2019, with most of this increase occurring in low- and middle-income countries (LMICs).
A simple skin test that would allow detection of Alzheimer's disease appears to be a realistic possibility in the future.
› Verified 1 days ago